Mrv1902 01281923412D 19 19 0 0 0 0 999 V2000 -4.6271 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6271 -0.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9126 -1.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1979 -0.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1979 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9126 0.4082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7686 -0.8294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7686 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4832 0.4082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0627 0.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3624 -0.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3629 0.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0736 0.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7842 0.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4950 0.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2057 0.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9163 0.0112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.6271 0.4216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2057 1.2421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 5 9 1 0 0 0 0 8 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 16 19 2 0 0 0 0 M END > DB02546 > drugbank > ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 > InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) > WAEXFXRVDQXREF-UHFFFAOYSA-N > C14H20N2O3 > 264.3202 > 264.147392516 > 3 > 39 > 28.38675845510354 > 1 > 3 > 0 > 1 > N-hydroxy-N'-phenyloctanediamide > 1.88 > 2.003969249333333 > -3.57 > 0 > 1 > 0 > 14.203978435931308 > 8.907535980245514 > -3.521337304210903 > 78.43 > 73.80510000000002 > 8 > 1 > 7.16e-02 g/l > mitoxantrone > 0 > DB02546 > EXPT02902 > approved; investigational > Vorinostat > Octanedioic acid hydroxyamide phenylamide; SAHA; SHH; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat; Vorinostatum > Zolinza $$$$